| Mon 22 Sep 2025, 8:01 | | PRIMARY HEALTH PROPERTIES PLC - Update to notice of interim dividend for shareholders on the South African register |
|
Update to notice of interim dividend for shareholders on the South African register
Primary Health Properties PLC
(Incorporated in the United Kingdom)
Company Number: 3033634
LSE Share Code: PHP
JSE Share Code: PHP
ISIN Code: GB00BYRJ5J14
LEI: 213800Y5CJHXOATK7X11
("PHP" or the "Company")
Update to Notice of Interim Dividend for Shareholders on the South African Register
The Company announces that the fourth quarterly interim dividend in 2025 of 1.775 pence per
ordinary share of a nominal value of 12.5 pence each ("Dividend") will be paid as an ordinary
dividend on Friday, 21 November 2025 ("Dividend Payment Date") to shareholders on the register
on 10 October 2025.
The Company also confirms, further to its announcement on RNS on 5 January 2023, that shareholders
on the UK share register ("UK Shareholders") may participate in a dividend reinvestment plan ("DRIP")
in respect of the current interim dividend and any future dividends. The DRIP is provided by Equiniti
Financial Services Limited ("Equiniti FS") and administered by PHP's registrars, Equiniti Limited
("Equiniti"), and provides UK Shareholders with the opportunity to reinvest dividend payments to
purchase additional ordinary shares in PHP in the market. The DRIP is currently not available to
shareholders on the South African ("SA") share register ("SA Shareholders"). SA Shareholders will
receive the fourth quarterly interim dividend in cash.
UK Shareholders who hold their ordinary shares in certificated form and who wish to participate in the
DRIP will need to ensure that a completed DRIP Application Form is received by Equiniti no later than
5:00pm UK time on Friday, 31 October 2025 (the "Election Date"). Shareholders who hold their
ordinary shares in CREST and who wish to participate in the DRIP must do so by submitting an election
by CREST input message by the Election Date.
The key dates for the Dividend are detailed in the timetable below.
Timetable 2025
Last day to trade (SA Shareholders) Tuesday, 7 October
Ex-dividend date (SA Shareholders) Wednesday, 8 October
Last day to trade (UK Shareholders) Wednesday, 8 October
Ex-dividend date (UK Shareholders) Thursday, 9 October
Record Date Friday, 10 October
Latest date for receipt by Equiniti of DRIP Application 5.00 p.m. UK time on Friday, 31 October
Forms and input of CREST elections (UK Shareholders)
Dividend Payment Date – CSDP/broker accounts Friday, 21 November
credited/updated//CREST credit date
Estimated DRIP purchase date (UK Shareholders) Friday, 21 November
DRIP shares credited/certificates posted Wednesday, 26 November
(UK Shareholders)
Note: The above dates and times are subject to change. Any changes will be released on RNS and
SENS as soon as practically possible.
To facilitate settlement of the dividend to SA Shareholders, share certificates may not be dematerialised
or rematerialised between Wednesday, 8 October 2025 (Ex-dividend date for SA Shareholders) and
Friday, 10 October 2025 (Record Date), both days inclusive. Shares cannot be moved between the
South African share register and the UK share register, and no such transfers of shares between the
South African share register and the UK share register shall be registered, between the date of this
announcement and the Record Date, both days inclusive.
Exchange Rate and Tax Implications
The Dividend will be paid in British pound sterling ("GBP") to UK Shareholders and South African Rand
("ZAR") to SA shareholders. SA Shareholders are advised that the currency exchange rate applicable
to the Dividend payable in ZAR will be 23.61 to 1.00 GBP ("Exchange Rate"), resulting in a gross local
dividend amount of 41.90775 ZAR cents per share. The Exchange Rate was fixed by the Company on
19 September 2025 and the date on which the GBP payment will be converted to ZAR will be 14
October 2025.
The Dividend should be regarded as a 'foreign dividend' for South African income tax and dividends tax
purposes and the funds will be paid from the United Kingdom.
Accordingly, shareholders will be paid a cash dividend per share as follows:
Dividend UK Shareholders SA Shareholders
(GBP pence) (ZAR cents)
Gross amount of ordinary dividend payable 1.775 41.90775
Less 20% SA dividends tax for SA Shareholders who N/A 8.38155
are SA tax residents*
Net ordinary dividend payable 1.775 33.52620
* SA dividends tax applies at the rate of 20% for SA Shareholders who are SA tax residents if an
exemption does not exist.
For the avoidance of doubt, SA dividends tax, and therefore the information provided in this
announcement, is only of direct application to SA Shareholders who are SA tax residents. The contents
of this announcement are not to be construed as legal or tax advice. SA Shareholders are advised to
consult their own legal, financial or tax adviser for tax advice and should direct any questions regarding
the application of the SA dividends tax to their CSDP, broker or the Company's Transfer Secretary.
The issued share capital of PHP is 2 570 139 680 ordinary shares of 12.5 pence.
For further information:
Primary Health Properties PLC
Richard Howell, Chief Financial Officer +44(0) 776 6072 272
Toby Newman, Company Secretary & Chief Legal Officer +44(0) 772 9047 959
The Company has a primary listing on the London Stock Exchange and a secondary listing on the JSE
Limited.
United Kingdom
22 September 2025
Sponsor: PSG Capital
Date: 22-09-2025 08:01:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.